NIRMAN AGRI GENETICS
|
NIRMAN AGRI GENETICS Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 31.57 | 17.46 | 6.72 | 2,560.20 | 54.70 |
| CEPS(Rs) | 32.37 | 17.99 | 6.87 | 10.01 | 0.21 |
| DPS(Rs) | 2.00 | - | - | - | - |
| Book NAV/Share(Rs) | 137.32 | 62.64 | 45.22 | 2,644.11 | 64.70 |
| Tax Rate(%) | 3.02 | 4.87 | 5.93 | 25.17 | 25.98 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 11.23 | 18.13 | 15.25 | 25.39 | 1.94 |
| EBIT Margin(%) | 11.03 | 17.63 | 14.93 | 25.37 | 1.94 |
| Pre Tax Margin(%) | 11.02 | 17.27 | 14.88 | 25.36 | 1.93 |
| PAT Margin (%) | 10.69 | 16.43 | 14.00 | 18.98 | 1.43 |
| Cash Profit Margin (%) | 10.96 | 16.93 | 14.32 | 18.99 | 1.43 |
| Performance Ratios | |||||
| ROA(%) | 32.12 | 28.08 | 22.38 | 67.38 | 3.33 |
| ROE(%) | 34.33 | 32.37 | 27.06 | 189.03 | 84.54 |
| ROCE(%) | 35.17 | 33.83 | 26.60 | 133.26 | 7.00 |
| Asset Turnover(x) | 3.00 | 1.71 | 1.60 | 3.55 | 2.33 |
| Sales/Fixed Asset(x) | 117.82 | 86.92 | 86.45 | 2,643.67 | - |
| Working Capital/Sales(x) | 2.43 | 4.30 | 4.12 | 3.59 | 3.62 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.01 | 0.01 | 0.01 | - | - |
| Receivable days | 37.88 | 45.09 | 52.86 | 65.50 | 58.69 |
| Inventory Days | 34.97 | 37.37 | 34.05 | 11.44 | 19.21 |
| Payable days | 6.09 | 21.32 | 11.09 | 26.33 | 39.43 |
| Valuation Parameters | |||||
| PER(x) | 6.23 | 9.18 | 12.27 | - | - |
| PCE(x) | 6.08 | 8.91 | 12.00 | - | - |
| Price/Book(x) | 1.43 | 2.56 | 1.82 | - | - |
| Yield(%) | 1.02 | - | - | - | - |
| EV/Net Sales(x) | 0.56 | 1.66 | 1.94 | 0.04 | 0.07 |
| EV/Core EBITDA(x) | 4.94 | 9.15 | 12.72 | 0.15 | 3.61 |
| EV/EBIT(x) | 5.06 | 9.41 | 12.99 | 0.15 | 3.61 |
| EV/CE(x) | 1.20 | 2.77 | 1.98 | 0.09 | 0.16 |
| M Cap / Sales | 0.67 | 1.67 | 1.91 | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 273.43 | 121.40 | 112.08 | 252.92 | - |
| Core EBITDA Growth(%) | 132.83 | 163.17 | 27.42 | 4,527.43 | - |
| EBIT Growth(%) | 133.72 | 161.36 | 24.83 | 4,524.86 | - |
| PAT Growth(%) | 143.03 | 159.76 | 56.45 | 4,580.44 | - |
| EPS Growth(%) | 80.86 | 159.76 | -99.74 | 4,580.44 | - |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | 0.02 | 0.04 | 0.54 | 15.33 |
| Current Ratio(x) | 32.06 | 3.14 | 4.24 | 2.82 | 2.81 |
| Quick Ratio(x) | 20.24 | 1.94 | 2.05 | 2.50 | 2.46 |
| Interest Cover(x) | 1,191.59 | 48.93 | 297.22 | 3,013.74 | 740.00 |
| Total Debt/Mcap(x) | - | 0.01 | 0.02 | - | - |
Compare Financial Ratios of peers of NIRMAN AGRI GENETICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NIRMAN AGRI GENETICS | ₹140.5 Cr | -0.5% | 6.9% | -44.6% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,327.1 Cr | 3.5% | 1.7% | -29.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,442.8 Cr | -1.3% | -7.5% | 15.7% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,065.4 Cr | -1.7% | -1.6% | -21.5% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,268.8 Cr | -3.5% | -11.1% | -31.1% | Stock Analytics | |
| INDO US BIOTECH | ₹259.3 Cr | -3.8% | -11.2% | -51.3% | Stock Analytics | |
NIRMAN AGRI GENETICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NIRMAN AGRI GENETICS | -0.5% |
6.9% |
-44.6% |
| SENSEX | 0.1% |
0.6% |
0.7% |
You may also like the below Video Courses
